Other studies reported a downregulation of Cyr61/CCN1 and CTGF/CCN2 expression by 2 μM VP during longer treatment in gastric cancer and glioma cell lines (Al-Moujahed et al., 2017; Kang et al., 2018). The gene discussed is CCN2; the disease is gastric cancer.